When two is better than three: Dual antithrombotic therapy cuts bleeding risk

(Brigham and Women's Hospital) Clinical trial finds that dabigatran dual therapy after stenting reduced bleeding risk for patients with atrial fibrillation compared with standard triple therapy.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news